vimarsana.com

Page 5 - Managed Access Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Humanigen, Inc : Humanigen Launches Managed Access Program for Lenzilumab

Humanigen, Inc. (Nasdaq: HGEN), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called 'cytokine storm,' announced today that lenzilumab is now

Humanigen s Antibody Lenzilumab Available Through Managed Access Program For Covid-19 Patients

(RTTNews) - Humanigen, Inc. (HGEN), Thursday said its antibody, Lenzilumab is now available for certain hospitalized Covid-19 patients through its.

vimarsana © 2020. All Rights Reserved.